October 2020

· 1 min read

Nitrosamine Impurities; What’s the Impact on IMPs

N-nitrosamines are a regulatory and industry hot topic and whilst the focus has been on marketed products rather than development portfolios, there is an impact on investigational medicinal product development and manufacture. This webinar, led by Paul Cummings, will discuss nitrosamine impurities including key considerations when developing an IMP, the risks of delaying a formal risk assessment and more.